Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach
Pathogens · 2025
DOI: 10.3390/pathogens14070692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Valeria Conciatori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Padua, 35121 Padua, Italy. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Pneumonia, Mycoplasma, Real-Time Polymerase Chain Reaction, High-Throughput Screening Assays. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mycoplasma pneumoniae is a significant causative agent of atypical pneumonia in both children and adults. Timely and accurate diagnosis is crucial for appropriate patient management. Conventional methods for detecting M. pneumoniae, such as culture and serology, exhibit several limitations regarding sensitivity, specificity, and turnaround time. In contrast, real-time PCR is considered the most reliable, rapid, and sensitive technique for the diagnosis of M. pneumoniae infection. In this study, we adapted and validated an in-house real-time PCR assay for use on the fully automated Panther Fusion® System. The validation process included two artificial samples, five external quality controls, and sixty-two patient samples. We evaluated the performance in terms of precision, sensitivity, linearity, and analytical sensitivity, comparing it to the original in-house assay. The Panther Fusion® System demonstrated a broad dynamic range (16–1.6 × 107 copies/reaction), a robust correlation (94%) with the in-house assay, and comparable sensitivity (46 copies/mL vs. 25 copies/mL). The concordance between the in-house real-time PCR and the Panther Fusion® System was 100% for both clinical samples and external quality controls. The adaptation of the test to the Panther Fusion® System enabled the inclusion of M. pneumoniae among the pathogens monitored for respiratory infection surveillance. Throughout 2024, we analyzed 2567 samples, with a peak positivity rate of 38% observed in August. These findings underscore the significance of employing the M. pneumoniae diagnostic assay on the Panther Fusion® System which proves valuable for the detection of M. pneumoniae infections. This platform offers the advantages of increased automation and greater throughput potential compared to other platforms, enhancing the efficiency of respiratory pathogen detection in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine, University of Padua, 35121 Padua, Italy.
- Microbiology and Virology Diagnostic Unit, Padua University Hospital, 35121 Padua, Italy.
- UOC Medicina di Laboratorio, Ospedale San Bassano, ULSS 7 Pedemontana, Bassano del Grappa, 36061 Vicenza, Italy.
ORCID-Profile: Valeria Conciatori, Sarah Di Sopra, Giuseppe Di Pietra, Cristiano Salata, Claudia Del Vecchio
Zitieren
APA
Conciatori, V., Di Sopra, S., Franchin, E., Bekas, I., Di Pietra, G., Castagliuolo, I., Salata, C., & Del Vecchio, C. (2025). Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach. Pathogens. https://doi.org/10.3390/pathogens14070692
Vancouver
Conciatori V, Di Sopra S, Franchin E, Bekas I, Di Pietra G, Castagliuolo I, et al. Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach. Pathogens. 2025. doi:10.3390/pathogens14070692
BibTeX
@article{Conciatori2025,
author = {Conciatori, Valeria and Di Sopra, Sarah and Franchin, Elisa and Bekas, Ioannis and Di Pietra, Giuseppe and Castagliuolo, Ignazio and Salata, Cristiano and Del Vecchio, Claudia},
title = {Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14070692}
}
EUVIMED